List of Tables
Table 1. Global Liposomal Amphoteracin B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Liposomal Amphoteracin B Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Liposomal Amphoteracin B Market Competitive Situation by Manufacturers in 2024
Table 4. Global Liposomal Amphoteracin B Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Liposomal Amphoteracin B Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Liposomal Amphoteracin B Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Liposomal Amphoteracin B Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Liposomal Amphoteracin B, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Liposomal Amphoteracin B, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomal Amphoteracin B, Product Type & Application
Table 12. Global Key Manufacturers of Liposomal Amphoteracin B, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomal Amphoteracin B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Amphoteracin B as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomal Amphoteracin B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Liposomal Amphoteracin B Sales by Region (2020-2025) & (K Units)
Table 18. Global Liposomal Amphoteracin B Sales Market Share by Region (2020-2025)
Table 19. Global Liposomal Amphoteracin B Sales by Region (2026-2031) & (K Units)
Table 20. Global Liposomal Amphoteracin B Sales Market Share by Region (2026-2031)
Table 21. Global Liposomal Amphoteracin B Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Liposomal Amphoteracin B Revenue Market Share by Region (2020-2025)
Table 23. Global Liposomal Amphoteracin B Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Liposomal Amphoteracin B Revenue Market Share by Region (2026-2031)
Table 25. North America Liposomal Amphoteracin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Liposomal Amphoteracin B Sales by Country (2020-2025) & (K Units)
Table 27. North America Liposomal Amphoteracin B Sales by Country (2026-2031) & (K Units)
Table 28. North America Liposomal Amphoteracin B Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Liposomal Amphoteracin B Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Liposomal Amphoteracin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Liposomal Amphoteracin B Sales by Country (2020-2025) & (K Units)
Table 32. Europe Liposomal Amphoteracin B Sales by Country (2026-2031) & (K Units)
Table 33. Europe Liposomal Amphoteracin B Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Liposomal Amphoteracin B Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Liposomal Amphoteracin B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Liposomal Amphoteracin B Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Liposomal Amphoteracin B Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Liposomal Amphoteracin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Liposomal Amphoteracin B Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Liposomal Amphoteracin B Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Liposomal Amphoteracin B Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposomal Amphoteracin B Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Liposomal Amphoteracin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Liposomal Amphoteracin B Sales (K Units) by Type (2020-2025)
Table 51. Global Liposomal Amphoteracin B Sales (K Units) by Type (2026-2031)
Table 52. Global Liposomal Amphoteracin B Sales Market Share by Type (2020-2025)
Table 53. Global Liposomal Amphoteracin B Sales Market Share by Type (2026-2031)
Table 54. Global Liposomal Amphoteracin B Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Liposomal Amphoteracin B Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Liposomal Amphoteracin B Revenue Market Share by Type (2020-2025)
Table 57. Global Liposomal Amphoteracin B Revenue Market Share by Type (2026-2031)
Table 58. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2020-2025)
Table 59. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2026-2031)
Table 60. Global Liposomal Amphoteracin B Sales (K Units) by Application (2020-2025)
Table 61. Global Liposomal Amphoteracin B Sales (K Units) by Application (2026-2031)
Table 62. Global Liposomal Amphoteracin B Sales Market Share by Application (2020-2025)
Table 63. Global Liposomal Amphoteracin B Sales Market Share by Application (2026-2031)
Table 64. Global Liposomal Amphoteracin B Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Liposomal Amphoteracin B Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Liposomal Amphoteracin B Revenue Market Share by Application (2020-2025)
Table 67. Global Liposomal Amphoteracin B Revenue Market Share by Application (2026-2031)
Table 68. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2020-2025)
Table 69. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2026-2031)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gilead Sciences Liposomal Amphoteracin B Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. Cipla Company Information
Table 76. Cipla Description and Business Overview
Table 77. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Cipla Liposomal Amphoteracin B Product
Table 79. Cipla Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Liposomal Amphoteracin B Distributors List
Table 83. Liposomal Amphoteracin B Customers List
Table 84. Liposomal Amphoteracin B Market Trends
Table 85. Liposomal Amphoteracin B Market Drivers
Table 86. Liposomal Amphoteracin B Market Challenges
Table 87. Liposomal Amphoteracin B Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Liposomal Amphoteracin B
Figure 2. Global Liposomal Amphoteracin B Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomal Amphoteracin B Market Share by Type: 2024 & 2031
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. Global Liposomal Amphoteracin B Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Liposomal Amphoteracin B Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Liposomal Amphoteracin B Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Liposomal Amphoteracin B Market Size (2020-2031) & (US$ Million)
Figure 12. Global Liposomal Amphoteracin B Sales (2020-2031) & (K Units)
Figure 13. Global Liposomal Amphoteracin B Average Price (US$/Unit) & (2020-2031)
Figure 14. Liposomal Amphoteracin B Report Years Considered
Figure 15. Liposomal Amphoteracin B Sales Share by Manufacturers in 2024
Figure 16. Global Liposomal Amphoteracin B Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Liposomal Amphoteracin B Players: Market Share by Revenue in Liposomal Amphoteracin B in 2024
Figure 18. Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Liposomal Amphoteracin B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Liposomal Amphoteracin B Sales Market Share by Country (2020-2031)
Figure 21. North America Liposomal Amphoteracin B Revenue Market Share by Country (2020-2031)
Figure 22. United States Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Liposomal Amphoteracin B Sales Market Share by Country (2020-2031)
Figure 25. Europe Liposomal Amphoteracin B Revenue Market Share by Country (2020-2031)
Figure 26. Germany Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Liposomal Amphoteracin B Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Liposomal Amphoteracin B Revenue Market Share by Region (2020-2031)
Figure 33. China Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Liposomal Amphoteracin B Sales Market Share by Country (2020-2031)
Figure 43. Latin America Liposomal Amphoteracin B Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Liposomal Amphoteracin B Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Liposomal Amphoteracin B Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Liposomal Amphoteracin B Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Liposomal Amphoteracin B by Type (2020-2031)
Figure 53. Global Revenue Market Share of Liposomal Amphoteracin B by Type (2020-2031)
Figure 54. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Liposomal Amphoteracin B by Application (2020-2031)
Figure 56. Global Revenue Market Share of Liposomal Amphoteracin B by Application (2020-2031)
Figure 57. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2020-2031)
Figure 58. Liposomal Amphoteracin B Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
